Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes

authors:

avatar Sandro Gentile 1 , avatar Felice Strollo 2 , * , avatar Antonio Ceriello 3 , 4

Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
Department of Endocrinology, Hospital Clinic de Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain
International Journal of Endocrinology and Metabolism: Vol.14, issue 2; e33997
published online: April 26, 2016
article type: Article Commentary
received: February 1, 2016
accepted: April 13, 2016
DOI: https://doi.org/10.5812/ijem.33997

how to cite: Gentile S, Strollo F, Ceriello A. Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes. Int J Endocrinol Metab. 2016;14(2):e33997. https://doi.org/10.5812/ijem.33997.

Acknowledgements

References

  • 1.

    Al Ajlouni M, Abujbara M, Batieha A, Ajlouni K. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus. Int J Endocrinol Metab. 2015;13(2). eeeee20776. [PubMed ID: 25926852]. https://doi.org/10.5812/ijem.20776.

  • 2.

    Blanco M, Hernandez MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445-53. [PubMed ID: 23886784]. https://doi.org/10.1016/j.diabet.2013.05.006.

  • 3.

    Gentile S, Agrusta M, Guarino G, Carbone L, Cavallaro V, Carucci I, et al. Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes. Acta Diabetol. 2011;48(2):121-5. [PubMed ID: 20091324]. https://doi.org/10.1007/s00592-009-0172-x.

  • 4.

    Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss KW. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Translational Endocrinol. 2014;1(4):145-50. https://doi.org/10.1016/j.jcte.2014.07.006.

  • 5.

    Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661-7. [PubMed ID: 14507228].

  • 6.

    Holstein A, Stege H, Kovacs P. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf. 2010;9(2):225-31. [PubMed ID: 20001763]. https://doi.org/10.1517/14740330903496402.